BCHE and Alzheimer disease: As inhibitors of monoamine oxidase and cholinesterase, they are considered to have potential therapeutic effects on various neuropsychiatric disorders such as Alzheimer’s disease (AD), depression, anxiety and some others (Hilber and Chapillon, 2005; Farzin and Mansouri, 2006; Zheng et al., 2009; Liu et al., 2014; He et al., 2015; Jiang et al., 2015; Liu et al., 2017; Li et al., 2018; Nasehi et al., 2018; Ebrahimi-Ghiri et al., 2019; Jiang et al., 2019; Nasehi et al., 2019; Mosaffa et al., 2021).